Gnrh
Hypogonadism, Male
Royal College of Surgeons, Irelandprotein_peptideActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 81/ 100
Competitive context
16 Active assets in the Hypogonadism, Male cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TESTOSTERONE UNDECYLATE University of Sao Paulo General Hospital | Phase 4 | BB |
TESTOSTERONE ENANTATE Tulane University | Phase 4 | BB |
TESTOSTERONE CIPIONATE University of Miami | Phase 4 | B |
CLOMIPHENE CITRATE University of Sao Paulo | Phase 2 | B |
Recombinant Ephb4-Hsa Fusion Protein Northwestern University | Phase 2 | CCC |
View all 17 →
Same molecule, other indications
Gnrh is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →